Literature DB >> 13801161

Lymph node reactivity in cancer patients.

M M BLACK, F D SPEER.   

Abstract

Entities:  

Keywords:  LYMPH NODES/pathology; NEOPLASMS/pathology

Mesh:

Year:  1960        PMID: 13801161

Source DB:  PubMed          Journal:  Surg Gynecol Obstet        ISSN: 0039-6087


× No keyword cloud information.
  9 in total

1.  Fallibility in carcinoma of the breast.

Authors:  H ATKINS
Journal:  Proc R Soc Med       Date:  1960-11

2.  The influence of conservative and radical surgery on the survival of patients with breast cancer.

Authors:  J E DEVITT
Journal:  Can Med Assoc J       Date:  1962-10-27       Impact factor: 8.262

3.  Obstructive lymphopathy.

Authors:  J I Burn
Journal:  Ann R Coll Surg Engl       Date:  1968-02       Impact factor: 1.891

4.  Factors affecting the survival of patients with ovarian carcinoma.

Authors:  A B Weingold; S Sall; M L Stone
Journal:  Bull N Y Acad Med       Date:  1967-09

5.  Prognostic significance of lymph node reactivity in patients with laryngeal carcinoma.

Authors:  C Stankiewicz
Journal:  Eur Arch Otorhinolaryngol       Date:  1994       Impact factor: 2.503

6.  Mediastinal biopsy for indeterminate chest lesions.

Authors:  S B Chandor; E A Stemmer; J W Calvin; J E Connolly
Journal:  Thorax       Date:  1966-11       Impact factor: 9.139

7.  Studies on homotransplantable lymphomas in hamsters. I. Histologic responses in lymphoid tissues and their relationship to metastasis.

Authors:  R L Carter; R K Gershon
Journal:  Am J Pathol       Date:  1966-10       Impact factor: 4.307

8.  Axillary lymph node morphology in women with in situ breast carcinoma. An autopsy study.

Authors:  M Nielsen; L Christensen; J Jensen; J L Thomsen; J A Andersen
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1988

9.  An analysis of clinical and histopathological features in 101 cases of carcinoma of breast in women under 35 years of age.

Authors:  T G Brightmore; W P Greening; I Hamlin
Journal:  Br J Cancer       Date:  1970-12       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.